BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2717531)

  • 1. Natural cytotoxicity of human serum. A natural IgM 'antibody' sensitizes transformed murine cells to the lytic action of complement.
    Bolande RP; Arnold JL; Mayer DC
    Pathol Immunopathol Res; 1989; 8(1):46-60. PubMed ID: 2717531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytolysis of human neuroblastoma cells by a natural IgM 'antibody'-complement system in pregnancy serum.
    Bolande RP; Mayer DC
    Cancer Invest; 1990; 8(6):603-11. PubMed ID: 2292053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a natural cytotoxic IgM "antibody" in human serum sensitizing L cells to complement.
    Bolande RP; Mayer DC
    Proc Soc Exp Biol Med; 1989 Sep; 191(4):387-90. PubMed ID: 2771965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-mediated cytolysis and azidothymidine are synergistic in HIV-1 suppression.
    Okada H; Wu X; Okada N
    Int Immunol; 1998 Jan; 10(1):91-5. PubMed ID: 9488159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen.
    Hunt KK; Shibata M; Gupta RK; Morton DL
    Cancer Immunol Immunother; 1992; 34(6):377-82. PubMed ID: 1563014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning of a human antibody directed against human neuroblastoma cells and specific for human translation elongation factor 1alpha.
    Schilbach K; Kreyenberg H; Geiselhart A; Niethammer D; Handgretinger R
    Tissue Antigens; 2004 Feb; 63(2):122-31. PubMed ID: 14705983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A naturally occurring complement dependent human IgM macroglobulin inhibitory to Ehrlich ascites tumor cells.
    Goff MM; Armentrout SA
    J Clin Lab Immunol; 1982 Dec; 9(3):163-7. PubMed ID: 7166749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells.
    Ollert MW; David K; Schmitt C; Hauenschild A; Bredehorst R; Erttmann R; Vogel CW
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4498-503. PubMed ID: 8633097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcine islet cells of Langerhans are destroyed by human complement and not by antibody-dependent cell-mediated mechanisms.
    Schaapherder AF; Wolvekamp MC; te Bulte MT; Bouwman E; Gooszen HG; Daha MR
    Transplantation; 1996 Jul; 62(1):29-33. PubMed ID: 8693539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of IgM antibodies which sensitize HIV-1-infected cells to cytolysis by homologous complement in long-term survivors of HIV infection.
    Okada N; Wu X; Okada H
    Microbiol Immunol; 1997; 41(4):331-6. PubMed ID: 9159407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. In vitro analysis of complement activation.
    Zhao Z; Termignon JL; Cardoso J; Chéreau C; Gautreau C; Calmus Y; Houssin D; Weill B
    Transplantation; 1994 Jan; 57(2):245-9. PubMed ID: 8310516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing of human cytomegalovirus-infected fibroblasts by antiviral antibody and complement.
    Middeldorp JM; Jongsma J; The TH
    J Infect Dis; 1986 Jan; 153(1):48-55. PubMed ID: 3001193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the immunoglobulin class of complement-dependent cytotoxic antibodies in serum of D23 hepatoma-bearing rats.
    Lando P; Gabriel J; Berzins K; Perlmann P
    Scand J Immunol; 1980; 11(3):253-60. PubMed ID: 9537053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma.
    Fukuda M; Nozaki C; Ishiguro Y; Horibe K
    Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of complement-mediated porcine endothelial cell cytotoxicity by human IgM natural antibody.
    Dalmasso AP; He T; Benson BA
    Transplant Proc; 1996 Apr; 28(2):535. PubMed ID: 8623251
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of cell-mediated tumor cell lysis and complement-induced cytotoxicity by trypan blue.
    Scornik JC; Ruiz P; Hoffman EM
    J Immunol; 1979 Sep; 123(3):1278-84. PubMed ID: 469250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of fetal and adult porcine islets with regard to Gal alpha (1,3)Gal expression and the role of human immunoglobulins and complement in islet cell cytotoxicity.
    Bennet W; Björkland A; Sundberg B; Davies H; Liu J; Holgersson J; Korsgren O
    Transplantation; 2000 Apr; 69(8):1711-7. PubMed ID: 10836385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent interleukin 2 (IL-2) inhibitory activity of human serum is due to rapid killing of IL-2-dependent mouse cells.
    Pruett SB; Lackey A
    Clin Exp Immunol; 1987 Sep; 69(3):624-31. PubMed ID: 3117461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody of patients with Guillain-Barré syndrome mediates complement-dependent cytolysis of rat Schwann cells: susceptibility to cytolysis reflects Schwann cell phenotype.
    Sawant-Mane S; Estep A; Koski CL
    J Neuroimmunol; 1994 Jan; 49(1-2):145-52. PubMed ID: 8294552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of terminal alpha-galactosyl residues from xenogeneic porcine endothelial cells. Decrease in complement-mediated cytotoxicity but persistence of IgG1-mediated antibody-dependent cell-mediated cytotoxicity.
    Watier H; Guillaumin JM; Piller F; Lacord M; Thibault G; Lebranchu Y; Monsigny M; Bardos P
    Transplantation; 1996 Jul; 62(1):105-13. PubMed ID: 8693523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.